Bank of America’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$320M Buy
966,912
+281,735
+41% +$95.9M 0.02% 544
2025
Q4
$272M Sell
685,177
-813,314
-54% -$360M 0.02% 611
2025
Q3
$683M Buy
1,498,491
+241,163
+19% +$98.2M 0.05% 359
2025
Q2
$410M Buy
1,257,328
+192,755
+18% +$53.3M 0.03% 499
2025
Q1
$287M Buy
1,064,573
+646,021
+154% +$166M 0.03% 585
2024
Q4
$98.5M Sell
418,552
-132,220
-24% -$34.8M 0.01% 1031
2024
Q3
$151M Sell
550,772
-80,340
-13% -$20.9M 0.01% 870
2024
Q2
$153M Buy
631,112
+146,219
+30% +$23.1M 0.01% 804
2024
Q1
$72.5M Buy
484,893
+168,660
+53% +$28.1M 0.01% 1228
2023
Q4
$60.5M Sell
316,233
-34,920
-10% -$5.95M 0.01% 1227
2023
Q3
$62.2M Sell
351,153
-1,190
-0.3% -$227K 0.01% 1160
2023
Q2
$66.9M Sell
352,343
-418,862
-54% -$83M 0.01% 1110
2023
Q1
$154M Buy
771,205
+467,996
+154% +$98.4M 0.02% 729
2022
Q4
$72.1M Buy
303,209
+65,400
+28% +$13.9M 0.01% 1073
2022
Q3
$47.6M Sell
237,809
-4,288
-2% -$818K 0.01% 1296
2022
Q2
$35.3M Sell
242,097
-35,160
-13% -$4.99M ﹤0.01% 1504
2022
Q1
$45.3M Buy
277,257
+12,779
+5% +$1.95M ﹤0.01% 1445
2021
Q4
$44.8M Sell
264,478
-39,706
-13% -$7.38M ﹤0.01% 1481
2021
Q3
$57.4M Buy
304,184
+1,403
+0.5% +$263K 0.01% 1267
2021
Q2
$51.3M Buy
302,781
+18,090
+6% +$2.65M 0.01% 1346
2021
Q1
$40.2M Buy
284,691
+16,064
+6% +$2.42M ﹤0.01% 1454
2020
Q4
$34.9M Sell
268,627
-43,364
-14% -$5.79M ﹤0.01% 1431
2020
Q3
$45.4M Sell
311,991
-11,040
-3% -$1.57M 0.01% 1138
2020
Q2
$47.8M Sell
323,031
-133,312
-29% -$18M 0.01% 1044
2020
Q1
$49.7M Buy
456,343
+233,925
+105% +$27M 0.01% 961
2019
Q4
$25.6M Sell
222,418
-59,291
-21% -$5.91M ﹤0.01% 1683
2019
Q3
$22.7M Buy
281,709
+18,909
+7% +$1.5M ﹤0.01% 1731
2019
Q2
$19.1M Buy
262,800
+634
+0.2% +$48.6K ﹤0.01% 1920
2019
Q1
$24.5M Buy
262,166
+164,065
+167% +$13.7M ﹤0.01% 1652
2018
Q4
$7.15M Sell
98,101
-30,067
-23% -$2.31M ﹤0.01% 2624
2018
Q3
$11.2M Sell
128,168
-133
-0.1% -$13.4K ﹤0.01% 2378
2018
Q2
$12.6M Sell
128,301
-20,737
-14% -$2.06M ﹤0.01% 2227
2018
Q1
$17.8M Buy
149,038
+25,686
+21% +$3.31M ﹤0.01% 1880
2017
Q4
$15.7M Buy
123,352
+48,455
+65% +$6.09M ﹤0.01% 2022
2017
Q3
$8.8M Buy
74,897
+26,859
+56% +$2.29M ﹤0.01% 2629
2017
Q2
$3.83M Buy
48,038
+8,369
+21% +$535K ﹤0.01% 3284
2017
Q1
$2.03M Sell
39,669
-7,295
-16% -$337K ﹤0.01% 3842
2016
Q4
$1.76M Buy
46,964
+21,079
+81% +$883K ﹤0.01% 3876
2016
Q3
$1.75M Sell
25,885
-15,687
-38% -$1.11M ﹤0.01% 3751
2016
Q2
$2.31M Buy
41,572
+12,800
+44% +$806K ﹤0.01% 3511
2016
Q1
$1.81M Sell
28,772
-45,592
-61% -$3.03M ﹤0.01% 3655
2015
Q4
$7M Buy
74,364
+45,251
+155% +$4.2M ﹤0.01% 2607
2015
Q3
$2.34M Sell
29,113
-13,339
-31% -$1.48M ﹤0.01% 3607
2015
Q2
$5.09M Buy
42,452
+16,659
+65% +$1.99M ﹤0.01% 2578
2015
Q1
$2.69M Buy
25,793
+14,875
+136% +$1.51M ﹤0.01% 2967
2014
Q4
$1.06M Sell
10,918
-7,036
-39% -$652K ﹤0.01% 3996
2014
Q3
$1.4M Sell
17,954
-57,667
-76% -$3.72M ﹤0.01% 3695
2014
Q2
$4.78M Buy
75,621
+67,821
+870% +$4.03M ﹤0.01% 2605
2014
Q1
$524K Sell
7,800
-4,711
-38% -$365K ﹤0.01% 4542
2013
Q4
$804K Buy
12,511
+2,090
+20% +$125K ﹤0.01% 4312
2013
Q3
$667K Sell
10,421
-65,343
-86% -$3.26M ﹤0.01% 4358
2013
Q2
$2.35M Buy
+75,764
New +$2.02M ﹤0.01% 3028

Other funds holding ALNY